The Iliac/SFA/Popliteal Center

Filter Your Results




The TAPE Method

Andrzej Boguszewski, MD; Michael Tucciarone, MD; James Torey, PA-C; and Thomas Davis, MD

February 2012—A novel intravascular ultrasound scoring system for peripheral CTO lesions.

One-Year Data From Medtronic's Complete SE SFA Study Presented

February 8, 2012—Medtronic, Inc. (Minneapolis, MN) announced the 1-year results of an international study of the Complete SE self-expanding vascular stent for the treatment …

Published 3-Year RESILIENT Data Support Bard’s LifeStent in the SFA

February 8, 2012—Co-Principal Investigator John R. Laird, MD, et al published 3-year follow-up data from the RESILIENT randomized trial in the Journal of Endovascular Therap…

Initial Data Presented on Eurocor’s Freeway Drug-Eluting Balloon

February 2, 2012—Eurocor GmbH (Bonn, Germany) announced that data from its ongoing FREEWAY study were presented at a company-sponsored symposium during the 2012 Leipzig Inte…

Editor’s Challenge

January 2012—A panel of interventional experts weighs in on how they would access and treat a series of challenging access case presentations.
With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark W. Burket, MD; Bruce H. Gray, DO; Craig Walker, MD; and Michael Wholey, MD, MBA

DURABILITY II 1-Year Data Presented for Covidien’s EverFlex Stent to Treat SFA Disease

January 24, 2012—Covidien (Mansfield, MA) announced that Co-National Principal Investigator Jon Matsumura, MD, presented 1-year results from the DURABILITY II study of the c…

ESPRIT I in Europe Evaluates Abbott’s Drug-Eluting BVS for PAD

December 22, 2011—Abbott Vascular (Santa Clara, CA) announced the initiation of the ESPRIT I clinical trial in Europe.The company stated that ESPRIT I is a single-arm, multi…

Bard Acquires Lutonix

December 20, 2011—CR Bard, Inc. (Murray Hill, NJ) announced that it has acquired Lutonix, Inc. (Maple Grove, MN) for approximately $225 million to be paid at closing, with a…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.